National Defense Authorization Act for Fiscal Year 2017

The pilot includes an evaluation of how reducing or eliminating the cost-sharing for specified high-value medications and services impacts:  (I) adherence to medication regimens; (II) quality measures; (III) health outcomes; and (IV) beneficiary experience.